{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T08:07:05Z","timestamp":1789200425630,"version":"build-2803163510"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T00:00:00Z","timestamp":1781654400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Congenital Heart Disease"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijcchd.2026.100691","type":"journal-article","created":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T16:38:23Z","timestamp":1782319103000},"page":"100691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comparative efficacy and safety of direct oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with adult congenital heart disease. Contemporary real-world propensity-matched retrospective cohort study"],"prefix":"10.1016","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9889-9285","authenticated-orcid":false,"given":"Dennis D.","family":"Kumi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Blankson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Animah","family":"Acheampong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Michael","family":"Odoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudhir","family":"Mungee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timir","family":"Baman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Mehrotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siddharth","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.ijcchd.2026.100691_bib1","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1161\/CIRCULATIONAHA.113.008396","article-title":"Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010","volume":"130","author":"Marelli","year":"2014","journal-title":"Circulation"},{"issue":"15","key":"10.1016\/j.ijcchd.2026.100691_bib2","first-page":"122","article-title":"Temporal trends in survival to adulthood among patients born with congenital heart disease","volume":"96","author":"Moons","year":"2010","journal-title":"Heart"},{"issue":"17","key":"10.1016\/j.ijcchd.2026.100691_bib3","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/CIRCULATIONAHA.109.866319","article-title":"Prevalence, incidence, and predictors of atrial arrhythmias in adults with congenital heart disease","volume":"120","author":"Bouchardy","year":"2009","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.ijcchd.2026.100691_bib4","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.hrthm.2023.05.009","article-title":"Atrial fibrillation in adult congenital heart disease and the general population","volume":"20","author":"Wu","year":"2023","journal-title":"Heart Rhythm"},{"issue":"8","key":"10.1016\/j.ijcchd.2026.100691_bib5","article-title":"Cardiometabolic risk factors in Mexican adults with congenital heart disease","volume":"2","author":"Garc\u00eda-Cruz","year":"2023","journal-title":"JACC (J Am Coll Cardiol): Advances"},{"issue":"8","key":"10.1016\/j.ijcchd.2026.100691_bib6","doi-asserted-by":"crossref","DOI":"10.31083\/j.rcm2408225","article-title":"Atrial fibrillation in adult congenital heart disease increases ischemic stroke risk Even at low CHA2DS2-VASc Score","volume":"24","author":"Lin","year":"2023","journal-title":"Rev Cardiovasc Med"},{"issue":"10","key":"10.1016\/j.ijcchd.2026.100691_bib7","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.acvd.2018.04.003","article-title":"Risk of thromboembolic complications in adult congenital heart disease: a literature review","volume":"111","author":"Karsenty","year":"2018","journal-title":"Archives of Cardiovascular Diseases"},{"key":"10.1016\/j.ijcchd.2026.100691_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.ppedcard.2022.101608","article-title":"Anticoagulation treatment in adult patients with congenital heart defects and bleeding-related mortality","volume":"68","author":"Al-Khaiat","year":"2023","journal-title":"Prog Pediatr Cardiol"},{"issue":"6","key":"10.1016\/j.ijcchd.2026.100691_bib9","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.21037\/cdt-20-631","article-title":"Anticoagulation management in adult patients with congenital heart disease: a narrative review","volume":"11","author":"Sinning","year":"2021","journal-title":"Cardiovasc Diagn Ther"},{"issue":"12","key":"10.1016\/j.ijcchd.2026.100691_bib10","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.ijcchd.2026.100691_bib11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"9921","key":"10.1016\/j.ijcchd.2026.100691_bib12","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1016\/S0140-6736(13)62343-0","article-title":"Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomized trials","volume":"383","author":"Ruff","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijcchd.2026.100691_bib13","unstructured":"TriNetX, LLC. TriNetX Analytics Network database. Accessed August 20, 2024. https:\/\/trinetx.com\/ ."},{"issue":"1","key":"10.1016\/j.ijcchd.2026.100691_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/pds.3334","article-title":"The incident user design in comparative effectiveness research","volume":"22","author":"Johnson","year":"2013","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"7","key":"10.1016\/j.ijcchd.2026.100691_bib15","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1001\/jama.2020.9151","article-title":"Immortal time bias in observational studies","volume":"325","author":"Yadav","year":"2021","journal-title":"JAMA"},{"issue":"12","key":"10.1016\/j.ijcchd.2026.100691_bib16","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1016\/j.jacc.2018.08.1029","article-title":"2018 AHA\/ACC guideline for the management of adults with congenital heart disease: a report of the American college of Cardiology\/American heart Association task force on clinical practice guidelines","volume":"73","author":"Stout","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.ijcchd.2026.100691_bib17","first-page":"363","article-title":"Landmark analysis at the 25-Year landmark point: a statistical primer","volume":"4","author":"Dafni","year":"2011","journal-title":"Circulation: Cardiovascular Quality and Outcomes"},{"issue":"3","key":"10.1016\/j.ijcchd.2026.100691_bib18","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"issue":"10","key":"10.1016\/j.ijcchd.2026.100691_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.0040297","article-title":"Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration","volume":"4","author":"Vandenbroucke","year":"2007","journal-title":"PLoS Med"},{"issue":"10","key":"10.1016\/j.ijcchd.2026.100691_bib20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.ijcchd.2026.100691_bib21","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ijcchd.2026.100691_bib22","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s40256-025-00720-5","article-title":"Safety and efficacy of DOAC versus VKA in adult congenital heart disease: a systematic review and meta-analysis","volume":"25","author":"Shakir","year":"2025","journal-title":"Am J Cardiovasc Drugs : drugs, devices, and other interventions"},{"key":"10.1016\/j.ijcchd.2026.100691_bib23","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijcard.2019.09.077","article-title":"Direct oral anticoagulants in adults with congenital heart disease \u2013 a single centre study","volume":"300","author":"Pujol","year":"2020","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcchd.2026.100691_bib24","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.ijcard.2020.11.024","article-title":"Direct oral anticoagulant use and outcomes in adult patients with Fontan circulation","volume":"327","author":"Kawamatsu","year":"2021","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcchd.2026.100691_bib25","article-title":"Direct oral anticoagulants compared to warfarin in adult Fontan patients","author":"Kazerouninia","year":"2022","journal-title":"Cardiovasc Drugs Ther"},{"issue":"43","key":"10.1016\/j.ijcchd.2026.100691_bib26","doi-asserted-by":"crossref","first-page":"4168","DOI":"10.1093\/eurheartj\/ehaa844","article-title":"Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients","volume":"41","author":"Freisinger","year":"2020","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.ijcchd.2026.100691_bib27","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11239-022-02763-w","article-title":"Reduced dose direct oral anticoagulants compared with warfarin with high time in therapeutic range in nonvalvular atrial fibrillation","volume":"55","author":"Jansson","year":"2023","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ijcchd.2026.100691_bib28","article-title":"Thromboprophylaxis and adult congenital heart disease: the latest on indications, risk scoring and therapy","volume":"19","author":"Paiva","year":"2025","journal-title":"Int J Cardiol Congenit Heart Dis"},{"key":"10.1016\/j.ijcchd.2026.100691_bib29","first-page":"131","article-title":"Use of apixaban in adults with congenital heart disease and atrial arrhythmias: the PROTECT-AR study","volume":"396","author":"Kartas","year":"2024","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ijcchd.2026.100691_bib30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ijcard.2019.06.014","article-title":"Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study","volume":"299","author":"Yang","year":"2020","journal-title":"Int J Cardiol"},{"issue":"4","key":"10.1016\/j.ijcchd.2026.100691_bib31","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s10557-017-6745-y","article-title":"Non vitamin K antagonist oral anticoagulants for ThromboEmbolic prevention in adult congenital heart disease (NOTE) investigators. Is initiating NOACs for atrial arrhythmias safe in adults with congenital heart disease?","volume":"31","author":"Yang","year":"2017","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["International Journal of Cardiology Congenital Heart Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666668526000406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666668526000406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T07:49:10Z","timestamp":1789199350000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666668526000406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S2666668526000406"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcchd.2026.100691","relation":{},"ISSN":["2666-6685"],"issn-type":[{"value":"2666-6685","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy and safety of direct oral anticoagulants versus warfarin in non-valvular atrial fibrillation patients with adult congenital heart disease. Contemporary real-world propensity-matched retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Congenital Heart Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcchd.2026.100691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"100691"}}